Furthermore, extensive research by Munjoz et al. provide a detailed presentation of the molecular aspect of the substance P/receptor for Neurokinin complex (SP/NKR) on the progression of breast cancer and the possibility of use of drugs that block receptors with expecting positive effects on the prognosis of the disease. Here, TAC1 is linked to breast carcinoma.